Alzheimer’s Disease Neuroimaging Initiative

5586 Total Publications

Year	Title	Author	Journal
2013	Discriminative Feature Selection for Uncertain Graph Classification.	Kong X, Yu P, Wang X, Ragin A.	Journal arXiv Prepr;
2013	Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease.	Lambert, J. C., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., … Amouyel, P.	Journal Nature Genetics;
2013	Visual ratings of atrophy in MCI: Prediction of conversion and relationship with CSF biomarkers.	Lehmann, M., Koedam, E. L., Barnes, J., Bartlett, J. W., Barkhof, F., Wattjes, M. P., … Fox, N. C.	Journal Neurobiology of Aging;
2013	Relationship between imaging biomarkers, age, progression and symptom severity in Alzheimer’s disease.	Dukart, J., Mueller, K., Villringer, A., Kherif, F., Draganski, B., Frackowiak, R., & Schroeter, M. L.	Journal Neuroimage: Clinical;
2013	Heart fatty acid binding protein and Aβ-associated Alzheimer’s neurodegeneration.	Rahul S Desikan, Wesley K Thompson, Dominic Holland, Christopher P Hess, James B Brewer, Henrik Zetterberg, Kaj Blennow, Ole A Andreassen, Linda K McEvoy, Bradley T Hyman, Anders M Dale, and for the Alzheimer’s Disease Neuroimaging Initiative.	Journal Molecular Neurodegeneration;
2013	A direct morphometric comparison of five labeling protocols for multi-atlas driven automatic segmentation of the hippocampus in Alzheimer’s disease	Nestor, S. M., Gibson, E., Gao, F. Q., Kiss, A., & Black, S. E.	Journal Neuroimage;
2013	Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people.	Wirth, M., Villeneuve, S., Haase, C. M., Madison, C. M., Oh, H., Landau, S. M., … Jagust, W. J.	Journal JAMA Neurology;
2013	Cerebral atrophy in mild cognitive impairment and Alzheimer disease: rates and acceleration.	Leung, K. K., Bartlett, J. W., Barnes, J., Manning, E. N., Ourselin, S., & Fox, N. C.	Journal Neurology;
2013	Structural interactions within the default mode network identified by Bayesian network analysis in Alzheimer’s disease.	Wang, Y., Chen, K., Yao, L., Jin, Z., & Guo, X.	Journal PloS One;
2013	Disease progression model in subjects with mild cognitive impairment from the Alzheimer’s disease neuroimaging initiative: CSF biomarkers predict population subtypes.	Samtani, M. N., Raghavan, N., Shi, Y., Novak, G., Farnum, M., Lobanov, V., … Narayan, V. a.	Journal British Journal of Clinical Pharmacology;